| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |